Athersys Hosting KOL Panel Event to Discuss TREASURE Data
Webinar scheduled for June 14, 2022 at 5:00 p.m. ET CLEVELAND–(BUSINESS WIRE)–$ATHX #investorconference–Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a panel discussion with leading neurology experts on Tuesday, June 14th at 5:00 p.m. ET. The event will feature four key opinion leaders … [Read more…]